CNC.NYSECentene CORP

10-Q: Centene Reports Strong Q1 2025 Earnings, Driven by Premium Growth and Efficient Cost Management

Sentiment:

Quarterly Report

📋All filings for Centene CORP
🔒Login to Follow

Centene Corporation announces a strong first quarter in 2025, with significant revenue growth and improved earnings per share, driven by its Medicare and Commercial segments.

Better than expectedThe company's total revenues increased 15% in the three months ended March 31, 2025, over the corresponding period in 2024, primarily driven by premium and membership growth in the PDP business along with strong product positioning and overall market growth in the Marketplace business.The SG&A expense ratio was 7.9% for the first quarter of 2025, compared to 8.9% in the first quarter of 2024.Diluted earnings per share (EPS) of $2.63, compared to $2.16 for the first quarter of 2024.Adjusted diluted EPS of $2.90, compared to $2.26 for the first quarter of 2024.

Summary

  • Centene Corporation's Q1 2025 shows a 15% increase in total revenues, reaching $46.6 billion.
  • Premium and service revenues grew by 17% to $42.5 billion.
  • Managed care membership stood at 27.9 million, a decrease of 2% year-over-year.
  • The Health Benefits Ratio (HBR) was 87.5%, compared to 87.1% in Q1 2024.
  • Selling, General, and Administrative (SG&A) expense ratio improved to 7.9% from 8.9% in Q1 2024.
  • Diluted earnings per share (EPS) increased to $2.63, up from $2.16 in Q1 2024.
  • Adjusted diluted EPS was $2.90, compared to $2.26 in the same period last year.
  • Operating cash flows provided $1.5 billion in cash during the quarter.
  • The company is navigating regulatory changes, including those related to the Inflation Reduction Act (IRA) and Medicaid eligibility redeterminations.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial performance, revenue growth, and efficient cost management. While there are some challenges related to membership decline and regulatory uncertainties, the overall tone is optimistic.

Positives

  • Significant revenue growth driven by the Medicare and Commercial segments.
  • Improved SG&A expense ratio indicates better cost management.
  • Strong growth in Medicare PDP and Marketplace memberships.
  • Increase in diluted and adjusted earnings per share.
  • Positive operating cash flow of $1.5 billion.

Negatives

  • Managed care membership decreased by 2% year-over-year.
  • Increase in HBR due to higher Medicaid HBR driven by influenza-and-like illnesses.
  • Medicaid gross margin decreased due to higher costs associated with influenza-and-like illnesses coupled with higher acuity post-redeterminations.

Risks

  • Regulatory uncertainties, including the expiration of enhanced eligibility for premium tax credits under the Inflation Reduction Act at the end of 2025.
  • Potential impacts from Medicaid eligibility redeterminations.
  • The company is protesting the results of Medicaid procurement awards in Georgia and Texas, which could impact future results if unsuccessful.
  • Potential impact of tariffs on healthcare costs.
  • Cyber-attacks or other data security incidents or our failure to comply with applicable privacy, data or security laws and regulations.

Future Outlook

Centene expects to receive net dividends from its insurance subsidiaries of approximately $2.2 billion and spend approximately $615 million in additional capital expenditures during the remainder of 2025. The company believes that its available cash, cash equivalents and investments, cash from operations, and cash available under its Revolving Credit Facility will be sufficient to finance its general operations and capital expenditures for at least 12 months from the date of the filing.

Management Comments

  • The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals.
  • We remain focused on the promise of delivering access to high-quality, affordable healthcare to all of our members and believe we are well positioned to meet the needs of the changing healthcare landscape.
  • With trends in the personalization of healthcare technology, we continue the use of data and analytics to improve the provider and member experience.
  • We continue to believe we have both the capacity and capability to successfully navigate industry changes to the benefit of our members, customers, providers and shareholders.

Industry Context

Centene's focus on government-sponsored healthcare programs aligns with the increasing demand for affordable healthcare solutions. The company's expansion in the Marketplace and Medicare segments reflects a strategic response to evolving market dynamics and regulatory changes, including the Inflation Reduction Act. The emphasis on local approaches and integrated services positions Centene to effectively serve under-insured and uninsured populations.

Comparison to Industry Standards

  • Centene's HBR of 87.5% is comparable to other managed care organizations, such as UnitedHealth Group and Anthem, but is subject to fluctuations based on specific market conditions and program changes.
  • The SG&A expense ratio of 7.9% demonstrates Centene's focus on cost management, which is a key performance indicator in the managed care industry.
  • Centene's membership numbers are significant, but the decrease in managed care membership reflects the broader industry trend of Medicaid redeterminations.
  • Centene's strategic focus on Medicare and Marketplace aligns with industry trends towards government-sponsored healthcare programs.

Legal Proceedings

  • The Company is routinely subjected to legal and regulatory proceedings in the normal course of business.
  • These matters can include, without limitation: periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, litigation arising out of general business activities, and disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups, vendors and others.

Stakeholder Impact

  • Shareholders: Positive financial results and efficient cost management are likely to benefit shareholders.
  • Members: The company's focus on high-quality, affordable healthcare aims to improve outcomes for members.
  • Providers: The company's efforts to improve the provider experience may lead to better relationships and service delivery.
  • Customers: The company's commitment to delivering cost-effective services benefits its government partners and commercial organizations.

Next Steps

  • Continue to work with state partners to match rates to acuity post-redeterminations.
  • Continue the use of data and analytics to improve the provider and member experience.
  • Continue to target initiatives to improve productivity, efficiencies and reduced organizational costs, as well as capital deployment activities, including stock repurchases, portfolio optimization and the evaluation of refinancing opportunities.

Key Dates

DateDescription
March 2021Enactment of the American Rescue Plan Act (ARPA), initially enhancing eligibility for premium tax credits in the Health Insurance Marketplace.
August 2022Enactment of the Inflation Reduction Act (IRA), extending enhanced eligibility for premium tax credits, expiring at the end of 2025.
March 31, 2023End of the period during which Medicaid membership increased by 3.6 million due to the public health emergency (PHE).
April 2023Start of Medicaid eligibility redeterminations related to the PHE.
January 2024Key coverage expansion provisions of the Consolidated Appropriations Act, 2023 went into effect, requiring states to provide 12 months of continuous coverage for children under Medicaid and CHIP.
January 2024Implementation of new third-party pharmacy benefits management (PBM) contract.
December 2024Health Net Federal Services concluded serving members upon the expiration of its TRICARE Managed Care Support Contract.
December 2024States have substantially completed their Medicaid unwinding processes.
January 2025Sunflower Health Plan commenced the contract to continue providing managed health care services through KanCare.
February 2025Sunshine Health commenced the expanded Statewide Medicaid Managed Care program.
March 5, 2025The Company entered into a new Credit Agreement and terminated all outstanding commitments and repaid all outstanding obligations under the Fourth Amended and Restated Credit Agreement.
March 2025Meridian Health Plan of Illinois, Inc., was selected by the Illinois Department of Healthcare and Family Services to continue providing Medicare and Medicaid services for dually eligible Illinoisans through a Fully Integrated Dual Eligible Special Needs Plan (FIDE SNP).
April 2025SilverSummit Healthplan, Inc., was selected by the Nevada Department of Health and Human Services to continue to provide services for its Medicaid managed care program.
July 2025Health Net Community Solutions was selected by the California Department of Health Care Services to provide managed dental health care services to beneficiaries of Medi-Cal.
July 2025Iowa Total Care was selected by the Iowa Department of Health and Human Services to continue providing Medicaid managed care services under the Iowa Health Link program.
October 2025Arizona Complete Health was selected by the Arizona Health Care Cost Containment System to provide managed care for the Arizona Long Term Care System (ALTCS).
January 2026Meridian Health Plan of Michigan, Inc., was selected by the MDHHS to provide highly integrated Medicare and Medicaid services for dually eligible Michiganders through a Highly Integrated Dual Eligible Special Needs Plan.
January 2026Buckeye Health Plan was selected by the Ohio Department of Medicaid to continue providing Medicare and Medicaid services for dually eligible individuals through a FIDE SNP.
January 2027Certain restrictions begin regarding beneficiaries dually enrolled in Medicare and a Medicaid Managed Care Plan to receive integrated care through the Medicaid company's Medicare Advantage Dual Eligible Special Needs Plans (D-SNPs).
2030Beneficiaries dually enrolled in Medicare and a Medicaid Managed Care Plan are required to receive integrated care through the Medicaid company's Medicare Advantage Dual Eligible Special Needs Plans (D-SNPs).

Keywords

Centene, earnings, financial results, healthcare, Medicaid, Medicare, Marketplace, membership, revenue, EPS, HBR, SG&A, Inflation Reduction Act, redeterminations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.